Cargando…
Synergistic protection of bone vasculature and bone mass by desferrioxamine in osteoporotic mice
It has previously been demonstrated that impaired angiogenesis is associated with metabolic abnormalities in bone in addition to osteoporosis (including postmenopausal osteoporosis). Enhancing vessel formation in bone is therefore a potential clinical therapy for osteoporosis. The present study cond...
Autores principales: | Wang, Liang, Jia, Peng, Shan, Yu, Hao, Yanming, Wang, Xiao, Jiang, Yu, Yuan, Ye, Du, Qiaoqiao, Zhang, Hui, Yang, Fan, Zhang, Wen, Sheng, Mao, Xu, Youjia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865796/ https://www.ncbi.nlm.nih.gov/pubmed/28901524 http://dx.doi.org/10.3892/mmr.2017.7451 |
Ejemplares similares
-
Synergistic anti-inflammatory and osteogenic n-HA/resveratrol/chitosan composite microspheres for osteoporotic bone regeneration
por: Li, Limei, et al.
Publicado: (2020) -
Desferrioxamine Reduces Oxidative Stress in the Lung Contusion
por: Basaran, Umit Nusret, et al.
Publicado: (2013) -
Expert consensus on the bone repair strategy for osteoporotic fractures in China
por: Zhang, Hao, et al.
Publicado: (2022) -
Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
por: Pepe, Alessia, et al.
Publicado: (2011) -
Effect of Cervus and Cucumis Peptides on Osteoblast Activity and Fracture Healing in Osteoporotic Bone
por: Wang, Ai-Yuan, et al.
Publicado: (2014)